Literature DB >> 24295406

Effect of pendant group on pDNA delivery by cationic-β-cyclodextrin:alkyl-PVA-PEG pendant polymer complexes.

Aditya Kulkarni1, Vivek Badwaik, Kyle DeFrees, Ryan A Schuldt, Dinara S Gunasekera, Cory Powers, Alexander Vlahu, Ross VerHeul, David H Thompson.   

Abstract

We have ppan class="Chemical">reviously shown that cationic-β-n>an class="Chemical">cyclodextrin:R-poly(vinyl alcohol)-poly(ethylene glycol) (CD+:R-PVA-PEG) pendant polymer host:guest complexes are safe and efficient vehicles for nucleic acid delivery, where R = benzylidene-linked adamantyl or cholesteryl esters. Herein, we report the synthesis and biological performance of a family of PVA-PEG pendant polymers whose pendant groups have a wide range of different affinities for the β-CD cavity. Cytotoxicity studies revealed that all of the cationic-β-CD:pendant polymer host:guest complexes have 100-1000-fold lower toxicity than branched polyethylenimine (bPEI), with pDNA transfection efficiencies that are comparable to bPEI and Lipofectamine 2000. Complexes formed with pDNA at N/P ratios greater than 5 produced particles with diameters in the 100-170 nm range and ζ-potentials of 15-35 mV. Gel shift and heparin challenge experiments showed that the complexes are most stable at N/P ≥ 10, with adamantyl- and noradamantyl-modified complexes displaying the best resistance toward heparin-induced decomplexation. Disassembly rates of fluoresceinated-pDNA:CD(+):R-PVA-PEG-rhodamine complexes within HeLa cells showed a modest dependence on host:guest binding constant, with adamantyl-, noradamantyl-, and dodecyl-based complexes showing the highest loss in FRET efficiency 9 h after cellular exposure. These findings suggest that the host:guest binding constant has a significant impact on the colloidal stability in the presence of serum and cellular uptake efficiency, whereas endosomal disassembly and transfection performance of cationic-β-CD:R-poly(vinyl alcohol)-poly(ethylene glycol) pendant polymer complexes appears to be controlled by the hydrolysis rates of the acetal grafts onto the PVA main chain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24295406      PMCID: PMC3899244          DOI: 10.1021/bm401096v

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  28 in total

1.  Complexation Thermodynamics of Cyclodextrins.

Authors:  Mikhail V. Rekharsky; Yoshihisa Inoue
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Polylysine-based transfection systems utilizing receptor-mediated delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-03-02       Impact factor: 15.470

Review 3.  siRNA therapeutics: big potential from small RNAs.

Authors:  R C C Ryther; A S Flynt; J A Phillips; J G Patton
Journal:  Gene Ther       Date:  2005-01       Impact factor: 5.250

4.  Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes.

Authors:  Aditya Kulkarni; Wei Deng; Seok-hee Hyun; David H Thompson
Journal:  Bioconjug Chem       Date:  2012-05-02       Impact factor: 4.774

5.  Facile synthesis of mono-6-amino-6-deoxy-alpha-, beta-, gamma-cyclodextrin hydrochlorides for molecular recognition, chiral separation and drug delivery.

Authors:  Weihua Tang; Siu-Choon Ng
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

7.  Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors.

Authors:  Aditya Kulkarni; Kyle DeFrees; Ryan A Schuldt; Alexander Vlahu; Ross VerHeul; Seok-Hee Hyun; Wei Deng; David H Thompson
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

8.  PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.

Authors:  Xiao-Xuan Liu; Palma Rocchi; Fan-Qi Qu; Shu-Quan Zheng; Zi-Cai Liang; Martin Gleave; Juan Iovanna; Ling Peng
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

9.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

Authors:  Mark E Davis
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

10.  Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery.

Authors:  Tooru Ooya; Hak Soo Choi; Atsushi Yamashita; Nobuhiko Yui; Yuko Sugaya; Arihiro Kano; Atsushi Maruyama; Hidetaka Akita; Rie Ito; Kentaro Kogure; Hideyoshi Harashima
Journal:  J Am Chem Soc       Date:  2006-03-29       Impact factor: 15.419

View more
  4 in total

1.  Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.

Authors:  Vivek Badwaik; Linjia Liu; Dinara Gunasekera; Aditya Kulkarni; David H Thompson
Journal:  Mol Pharm       Date:  2016-02-22       Impact factor: 4.939

2.  Efficient pDNA Delivery Using Cationic 2-Hydroxypropyl-β-Cyclodextrin Pluronic-Based Polyrotaxanes.

Authors:  Vivek Badwaik; Yawo Mondjinou; Aditya Kulkarni; Linjia Liu; Asher Demoret; David H Thompson
Journal:  Macromol Biosci       Date:  2015-08-10       Impact factor: 4.979

3.  Binding abilities of polyaminocyclodextrins: polarimetric investigations and biological assays.

Authors:  Marco Russo; Daniele La Corte; Annalisa Pisciotta; Serena Riela; Rosa Alduina; Paolo Lo Meo
Journal:  Beilstein J Org Chem       Date:  2017-12-18       Impact factor: 2.883

4.  Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules.

Authors:  Shayak Samaddar; Joshua Mazur; Devin Boehm; David H Thompson
Journal:  Int J Nanomedicine       Date:  2019-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.